CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 68 filers reported holding CASI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,222,000 | +1.3% | 10,150,000 | 0.0% | 0.02% | +26.7% |
| Q4 2021 | $8,120,000 | -32.8% | 10,150,000 | 0.0% | 0.02% | -34.8% |
| Q3 2021 | $12,079,000 | -23.2% | 10,150,000 | 0.0% | 0.02% | -20.7% |
| Q2 2021 | $15,733,000 | -35.4% | 10,150,000 | 0.0% | 0.03% | -38.3% |
| Q1 2021 | $24,360,000 | +18.0% | 10,150,000 | +45.0% | 0.05% | +11.9% |
| Q4 2020 | $20,650,000 | +95.6% | 7,000,000 | +1.4% | 0.04% | +68.0% |
| Q3 2020 | $10,557,000 | – | 6,900,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields & Co., LLC | 951,064 | $7,827,000 | 4.06% |
| Wellington Shields Capital Management, LLC | 855,056 | $7,037,000 | 1.16% |
| Manatuck Hill Partners, LLC | 15,090 | $124,000 | 0.05% |
| Moors & Cabot, Inc. | 22,935 | $187,000 | 0.02% |
| Perceptive Advisors | 43,682 | $360,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 120,000 | $988,000 | 0.01% |
| ALPS ADVISORS INC | 125,015 | $1,029,000 | 0.01% |
| MetLife Investment Management, LLC | 26,316 | $217,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 136,518 | $1,124,000 | 0.00% |
| Private Advisor Group, LLC | 15,001 | $122,000 | 0.00% |